ClinicalTrials.gg
RecruitingNCT04244942Updated Nov 12, 2026

CERAMENT™| Bone Void Filler Device Registry

An observational study in Orthopedic Disorder, sponsored by BONESUPPORT AB. Recruiting at 13 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by BONESUPPORT AB · Observational

How we know

From the registry’s dates

  • Started Mar 2020; still recruiting 6 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

A device registry to compile data on the performance of CERAMENT BONE VOID FILLER in normal use.

Read the detailed description

A device registry to compile data on the performance of CERAMENT BONE VOID FILLER in normal use.

02

Conditions studied

  • Orthopedic Disorder
03

In context

Musculoskeletal Diseases

753 studies on the registry are indexed under Musculoskeletal Diseases; 164 are open to participants now.

This study's planned enrollment of 300 is above the median of 120 across 207 observational studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

BONESUPPORT AB is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The racial, gender, and ethnic characteristics of the individuals approached for participation in this Observational Registry Study shall reflect the demographics of patients that would ordinarily received CERAMENT BVF for the treatment of their condition at the designated investigative centers. No individuals shall be excluded from participation in the Observational Registry Study based on race, nationality, ethnicity, gender or sexuality.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years and over (on the day of surgery)
  • Receive CERAMENT BVF as a component of their treatment at a participating, contracted center or healthcare provider, in accordance with the IFU for the implanted product
  • In receipt of patient information leaflet and have signed appropriately designed

Exclusion criteria

Exclusion Criteria:

  • Any exclusion criteria as per IFU for CERAMENT BVF
  • Any off-label use
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
18 Months
Patient registry
Yes

Interventions

  • DeviceCERAMENT BVF

    CERAMENT BONE VOID FILLER is a synthetic biphasic bone graft substitute.

06

What researchers measure

Primary outcomes

  1. Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 12 months

  2. Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 18 months

  3. Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 12 months

  4. Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 18 months

  5. Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 12 and 18 months

  6. Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 12 months

  7. adverse device events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Adverse device events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 18 months

  8. SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 12 months

  9. SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months

    Time frame: 18 months

Secondary outcomes

  1. Radiological assessment at 6 and 12 months. Objective assessment of regeneration

    Bone healing

    Time frame: 6 Months

  2. Radiological assessment at 6 and 12 months. Objective assessment of regeneration

    Bone healing

    Time frame: 12 Months

  3. Pain VAS score

    Pain assessment at 6,12, and 18 months

    Time frame: 6, 12, and 18 Months

  4. EQ-5D-3L

    Functional assessment at 6, 12, and 18 months

    Time frame: 6, 12, and 18 months

07

Study locations

11 of 13 sites recruiting
  • HonorHealth
    Scottsdale, Arizona 85258, United States
    Recruiting
    • Judd Cummings, MD · Contactjcummings@oso.md · 16022588500
    • Judd Cummings, MD · Principal investigator
  • Golden Orthopedic Knee, Hip, Shoulder and Foot Center
    Boca Raton, Florida 33434, United States
    Recruiting
  • Sports and Orthopedic Center
    Boca Raton, Florida 33434, United States
    Recruiting
  • Dr. Peter Merkle
    Pompano Beach, Florida 33064, United States
    Recruiting
  • Florida Orthopedic Foot & Ankle Center
    Sarasota, Florida 34233, United States
    Recruiting
  • James Cottom
    Sarasota, Florida 34233, United States
    Recruiting
  • Indiana University
    Indianapolis, Indiana 46202, United States
    Terminated

    Not enrolling at this site.

  • OrthoIndy
    Indianapolis, Indiana 46278, United States
    Completed

    Not enrolling at this site.

  • University of Kentucky
    Lexington, Kentucky 40536, United States
    Recruiting
    • Stephen Duncan, MD · Contactstdunc2@uky.edu
    • Stephen Duncan, MD · Principal investigator
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
    Recruiting
    • Santiago Lozano-Calderon, MD, PhD · Contact
    • Santiago Lozano-Calderon, MD, PhD · Principal investigator
  • The Research Foundation of The State University of New York
    Syracuse, New York 13210, United States
    Recruiting
    • Kayla Sweeney · Contactsweenkay@upstate.edu · 3154648618
    • Timothy Damron, MD · Principal investigator
  • OrthoCarolina
    Charlotte, North Carolina 28207, United States
    Recruiting
    • Justin Norwood · Contactjustin.norwood@orthocarolina.com · 704-323-2267
    • Carroll P Jones, M.D. · Principal investigator
    • Kent Ellington, M.D. · Sub investigator
    • Scott Shawen, M.D. · Sub investigator
    • Todd Irwin, M.D. · Sub investigator
  • University Hospitals Cleveland Medical Center
    Cleveland, Ohio 44106, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2020 (actual). Primary completion is estimated for Mar 2028, 96 months after the start.

Of 107 observational studies under Musculoskeletal Diseases, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 74. This study's planned 96 months is above that.

Musculoskeletal Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2020
First posted
Jan 28, 2020
StartActual
Mar 30, 2020
Primary completionEst.
Mar 30, 2028
CompletionEst.
Mar 30, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04244942
Lead sponsor
BONESUPPORT AB
Responsible party
Sponsor
First posted
Jan 28, 2020
Start date
Mar 30, 2020
Primary completion
Mar 30, 2028 (estimated)
Completion
Mar 30, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Brian M Bartholdi
Contact
brian.bartholdi@bonesupport.com
6178923927

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion